Since SREBP-1c controls the expression of lipogenic enzymes, this suggests that a decrease in lipogenesis could contribute to the EPA protective effect from HFD-induced obesity. The gene discussed is SREBF1; the disease is obesity due to melanocortin 4 receptor deficiency.